CVS Caremark® defines future of pharmacy benefit management
CVS Caremark, the leading pharmacy benefit manager and CVS Health company, has announced a renewed pledge to enhance transparency, reduce drug costs, and improve clinical care. The Caremark Client and Member Pledge focuses on:
1. Delivering greater affordability with an average out-of-pocket cost of less than $8 for a 30-day supply.
2. Promoting lowest net cost drugs.
3. Strengthening alignment between benefit design, physician choice, and patient need.
4. Innovating for greater transparency with the new TrueCost™ solution.
5. Encouraging pharmacy models that deliver rebate value directly to patients.
6. Improving relations with pharmacies.
7. Changing the trajectory of drug costs.
CVS Caremark aims to be a counterweight against pharmaceutical price hikes and continue putting medicine within reach for millions of Americans.
CVS Caremark, il principale gestore di benefici farmaceutici e azienda di CVS Health, ha annunciato un impegno rinnovato per migliorare la trasparenza, ridurre i costi dei farmaci e migliorare l'assistenza clinica. Il Caremark Client and Member Pledge si concentra su:
1. Offrire una maggiore accessibilità con un costo medio di meno di 8 euro per una fornitura di 30 giorni.
2. Promuovere i farmaci a costo netto più basso.
3. Rafforzare l'allineamento tra il design dei benefici, la scelta del medico e le necessità del paziente.
4. Innovare per una maggiore trasparenza con la nuova soluzione TrueCost™.
5. Incentivare modelli farmaceutici che offrono direttamente ai pazienti il valore dei rimborsi.
6. Migliorare le relazioni con le farmacie.
7. Cambiare l'andamento dei costi dei farmaci.
CVS Caremark mira a essere un contrappeso contro gli aumenti dei prezzi farmaceutici e a continuare a rendere i farmaci accessibili a milioni di americani.
CVS Caremark, el principal administrador de beneficios farmacéuticos y empresa de CVS Health, ha anunciado un compromiso renovado para mejorar la transparencia, reducir los costos de los medicamentos y mejorar la atención clínica. La Promesa a Clientes y Miembros de Caremark se enfoca en:
1. Ofrecer una mayor asequibilidad con un costo promedio de bolsillo de menos de $8 para un suministro de 30 días.
2. Promover los medicamentos de costo neto más bajo.
3. Fortalecer la alineación entre el diseño de beneficios, la elección del médico y las necesidades del paciente.
4. Innovar para una mayor transparencia con la nueva solución TrueCost™.
5. Fomentar modelos farmacéuticos que entreguen el valor de los reembolsos directamente a los pacientes.
6. Mejorar las relaciones con las farmacias.
7. Cambiar la trayectoria de los costos de los medicamentos.
CVS Caremark busca ser un contrapeso contra los aumentos de precios farmacéuticos y continuar haciendo que los medicamentos sean accesibles para millones de estadounidenses.
CVS Caremark는 선도적인 약국 혜택 관리 업체이자 CVS Health의 자회사로서, 투명성을 개선하고 약품 비용을 줄이며 임상 치료를 향상시키기 위한 새롭게 다짐을 발표했습니다. Caremark 고객 및 회원 서약은 다음에 중점을 두고 있습니다:
1. 30일 분량의 평균 본인 부담 비용이 $8 미만으로 더 큰 경제성을 제공하기.
2. 최저 순 비용 약품을 촉진하기.
3. 혜택 설계, 의사 선택 및 환자의 필요 간의 정렬을 강화하기.
4. 새로운 TrueCost™ 솔루션을 통해 더 큰 투명성을 위한 혁신.
5. 환자에게 직접 리베이트 가치를 제공하는 약국 모델 장려하기.
6. 약국과의 관계 개선하기.
7. 약값 상승 궤도 변경하기.
CVS Caremark는 제약 가격 인상에 대한 방어력을 제공하고 수백만 미국인에게 약품을 접근 가능하게 만들기 위해 계속 노력할 것입니다.
CVS Caremark, le principal gestionnaire de prestations pharmaceutiques et entreprise de CVS Health, a annoncé un engagement renouvelé pour améliorer la transparence, réduire les coûts des médicaments et améliorer les soins cliniques. La Promesse aux Clients et Membres Caremark se concentre sur :
1. Offrir une plus grande accessibilité avec un coût moyen de moins de 8 $ pour un approvisionnement de 30 jours.
2. Promouvoir les médicaments au coût net le plus bas.
3. Renforcer l'alignement entre le design des prestations, le choix du médecin et les besoins du patient.
4. Innover pour une plus grande transparence avec la nouvelle solution TrueCost™.
5. Encourager des modèles de pharmacie qui renvoient directement la valeur des remises aux patients.
6. Améliorer les relations avec les pharmacies.
7. Changer la trajectoire des coûts des médicaments.
CVS Caremark vise à être un contrepoids face aux hausses de prix pharmaceutiques et à continuer à rendre les médicaments accessibles à des millions d'Américains.
CVS Caremark, der führende Anbieter von Arzneimittelvergünstigungen und ein Unternehmen von CVS Health, hat ein erneuertes Engagement zur Verbesserung der Transparenz, zur Senkung der Arzneimittelpreise und zur Verbesserung der klinischen Versorgung angekündigt. Das Caremark Kunden- und Mitgliederversprechen konzentriert sich auf:
1. Höhere Erschwinglichkeit mit einem durchschnittlichen Eigenanteil von weniger als 8 $ für eine 30-Tage-Versorgung.
2. Förderung der Arzneimittel mit den niedrigsten Nettokosten.
3. Stärkung der Ausrichtung zwischen Leistungsdesign, Arztwahl und Patientenbedarf.
4. Innovation für mehr Transparenz mit der neuen TrueCost™-Lösung.
5. Förderung von Apothekenmodellen, die den Wert von Rabatten direkt an die Patienten weitergeben.
6. Verbesserung der Beziehungen zu Apotheken.
7. Veränderung der Entwicklung der Arzneimittelpreise.
CVS Caremark verfolgt das Ziel, ein Gegengewicht zu den Preiserhöhungen von Arzneimitteln zu sein und weiterhin Medikamente für Millionen Amerikaner zugänglich zu machen.
- Average out-of-pocket cost for members is less than $8 for a 30-day supply of medicine
- Introduction of TrueCost™ solution for greater transparency and alignment of costs
- 99% of negotiated rebates are passed through to clients
- Commitment to provide insulin under $25 and make it broadly available to all Americans
- Focus on promoting low-list price, low net cost drugs
- None.
CVS Caremark’s pledge highlights significant strategic commitments that can deeply influence their financial standing. Lowering drug costs and offering more transparency can lead to increased trust and customer loyalty. By promoting generics and biosimilars, CVS Caremark aims to reduce costs significantly, which could enhance their profitability. Furthermore, initiatives like TrueCost™, which aligns client and pharmacy reimbursement costs, can optimize operational efficiency. This move can also attract more clients looking for cost-effective solutions, potentially boosting revenue. Investors should watch for the realization of these pledges, as they could translate into stronger financial performance and potentially higher stock valuations.
From a market perspective, CVS Caremark’s renewed promises underscore a robust competitive strategy. The focus on transparency and affordability directly addresses common pain points within the pharmacy benefits management sector. By offering low-cost generics and biosimilars, CVS stands to dominate a cost-conscious market segment. Moreover, by passing rebates to patients and improving pharmacy relations, CVS aims to fortify customer and partner loyalty. These strategies could potentially increase market share, especially as transparency becomes a differentiating factor in healthcare choices. Investors should note the long-term market positioning advantages these commitments might yield.
On the clinical front, CVS Caremark’s initiatives to align benefit design with physician choice and patient needs are crucial. The real-time updates on benefits and formulary changes can reduce treatment delays, ensuring patients receive timely and appropriate care. This alignment can lead to better health outcomes, which is a significant value proposition in the healthcare industry. Moreover, initiatives to combat high drug prices and increase the availability of cost-effective alternatives like generic insulin can substantially impact public health. For stakeholders, these clinical improvements can translate into a more efficient healthcare system with potentially lower overall costs.
CVS Caremark pledges to accelerate transparency, drive to lowest net cost prescription drugs, strengthen pharmacy relations, and deliver the best clinical care in pharmacy
"The way we have done our work over the past few decades has driven greater cost savings, better care, and more robust benefits for the Americans we serve," said David Joyner, president of CVS Caremark. "Our work is rooted in greater simplicity and transparency for those who pay for pharmacy benefits, for people who take medicine, and for the pharmacies that serve our patients."
The Caremark Client and Member Pledge includes our commitments to:
- Deliver greater affordability. We are dedicated to driving affordability for prescription drugs. By continuing to promote generics, expand availability of biosimilars, and secure significant discounts on brand-name medications, we ensure Caremark members pay an average out-of-pocket cost of less than
$8 - Promote lowest net cost drugs. We provide choice to our clients who design the benefits that are best for their members, and as part of that work, we continue to promote and advocate for low-list price, low net cost drugs.
- Strengthen the alignment between client benefit design, physician choice, and patient need. We will continue to drive transparent prescriber connectivity — with real-time updates on benefit and formulary changes to reduce delays. We continue to closely align to and advocate for client needs, patient needs, and doctors' orders.
- Innovate to drive greater transparency. Our new TrueCost™ solution aligns client and pharmacy reimbursement specific costs, provides greater transparency, and includes additional dispensing fees for the services pharmacists provide. We will continue to offer differential reimbursement to independent and rural community pharmacies to maintain member access.
- Encourage pharmacy models that deliver rebate value directly to patients. Today,
99% of rebates we negotiate are passed through to clients, which they use to pay down the cost of benefits. With our TrueCost model, we return savings to patients directly at the pharmacy counter, which we do for employees at CVS Health today. - Improve relations with pharmacies. We will make it easier to do business with us by building upon what we have done: proactively addressing pharmacy access through partnering with rural pharmacies, updating technology for seamless transactions, making reimbursement transparent, and delivering a consistent experience at the counter.
- Change the trajectory of drug costs. Building on our history of standing with clients and consumers against pharmaceutical company price hikes, we will be the counterweight to stop price gouging. Through our formulary strategies to drive down costs, we continue to put medicine within reach — like breaking down the patent wall associated with high-priced Humira and providing insulin under
$25
"We all want affordable access to prescription drugs, and Caremark will continue to drive down costs, improve care, and accelerate transparency," Joyner said. "For our thousands of clients and millions of Americans, Caremark is the difference between affording medicine and going without. We take our commitments to heart and will deliver on our promise to everyone we serve."
About CVS Health
CVS Health® is the leading health solutions company, broadening access to care for millions of people nationwide. We improve the health of communities across America through our local presence, digital channels and with over 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses, and nurse practitioners. We support individuals with their health – whether that's managing health conditions, staying compliant with their medications or accessing affordable health services in the most convenient ways. Our goal is to create seamless connections across the health care system, simplifying the experience and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media.
Media contact
David Whitrap
View original content to download multimedia:https://www.prnewswire.com/news-releases/cvs-caremark-defines-future-of-pharmacy-benefit-management-302204115.html
SOURCE CVS Health
FAQ
What is CVS Caremark's new pledge for pharmacy benefit management?
How much is the average out-of-pocket cost for CVS Caremark members?
What is the TrueCost™ solution introduced by CVS Caremark (CVS)?
How much of the rebates negotiated by CVS Caremark (CVS) are passed through to clients?
What is CVS Caremark's (CVS) commitment regarding insulin costs?
